Madrigal Pharmaceuticals, X4 Pharmaceuticals and Day One Biopharmaceuticals secured their maiden approvals this year in metabolic dysfunction-associated steatohepatitis, WHIM syndrome and pediatric ...
Russia announces the development of an mRNA cancer vaccine, slated for a 2025 launch. Pre-clinical trials demonstrate tumor suppression and metastasis reduction. AI integration promises to ...
Background: Infant immunization is an effective public health intervention to reduce the morbidity and mortality of vaccine preventable ... Progress in Bacillus Calmette-Guerin (BCG) immunization ...
1-3 Gianotti-Crosti syndrome has also been identified following vaccinations, including after the influenza, Tdap, polio, measles, Japanese encephalitis, hepatitis B, and bacillus Calmette-Guérin ...